Grasso G, Alafaci C, Macdonald RL. Management of aneurysmal subarachnoid hemorrhage: State of the art and future perspectives. Surg Neurol Int. 2017;8:11.
Article PubMed PubMed Central Google Scholar
Li K, Barras CD, Chandra RV, Kok HK, Maingard JT, Carter NS, et al. A Review of the Management of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2019;126:513–27.
Veldeman M, Höllig A, Clusmann H, Stevanovic A, Rossaint R, Coburn M. Delayed cerebral ischaemia prevention and treatment after aneurysmal subarachnoid haemorrhage: a systematic review. Br J Anaesth. 2016;117(1):17–40.
Article CAS PubMed PubMed Central Google Scholar
Spencer P, Jiang Y, Liu N, Han J, Li Y, Vodovoz S, et al. Update: Microdialysis for Monitoring Cerebral Metabolic Dysfunction after Subarachnoid Hemorrhage. J Clin Med. 2020;10(1):100.
Article PubMed PubMed Central Google Scholar
Hemphill JC, Andrews P, De Georgia M. Multimodal monitoring and neurocritical care bioinformatics. Nat Rev Neurol. 2011;7(8):451–60.
Korbakis G, Vespa PM. Multimodal neurologic monitoring. Handb Clin Neurol. 2017;140:91–105.
Article CAS PubMed Google Scholar
Le Roux P, Menon DK, Citerio G, Vespa P, Bader MK, Brophy GM, et al. Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care: a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine. Neurocritical Care. 2014;21(Suppl 2):S1-26.
Tasneem N, Samaniego EA, Pieper C, Leira EC, Adams HP, Hasan D, et al. Brain Multimodality Monitoring: A New Tool in Neurocritical Care of Comatose Patients. Crit Care Res Pract. 2017;2017:6097265.
PubMed PubMed Central Google Scholar
Ungerstedt U. Microdialysis–principles and applications for studies in animals and man. J Intern Med. 1991;230(4):365–73.
Article CAS PubMed Google Scholar
Hutchinson PJ, Jalloh I, Helmy A, Carpenter KL, Rostami E, Bellander BM, et al. Consensus statement from the 2014 In-ternational Microdialysis Forum. Intensive Care Med. 2015;41(9):1517–28.
Article PubMed PubMed Central Google Scholar
Staub F, Graf R, Gabel P, Köchling M, Klug N, Heiss WD. Multiple interstitial substances measured by microdialysis in patients with subarachnoid hemorrhage. Neurosurgery. 2000;47(5):1106–15. discussion 15-6.
Article CAS PubMed Google Scholar
Jabbarli R, Pierscianek D, Darkwah Oppong M, Sato T, Dammann P, Wrede KH, et al. Laboratory biomarkers of delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review. Neurosurg Rev. 2020;43(3):825–33.
Maurer MH, Haux D, Unterberg AW, Sakowitz OW. Proteomics of human cerebral microdialysate: From detection of bi-omarkers to clinical application. Proteomics Clin Appl. 2008;2(3):437–43.
Article CAS PubMed Google Scholar
Maurer MH, Haux D, Sakowitz OW, Unterberg AW, Kuschinsky W. Identification of early markers for symptomatic vaso-spasm in human cerebral microdialysate after subarachnoid hemorrhage: preliminary results of a proteome-wide screening. J Cereb Blood Flow Metab. 2007;27(10):1675–83.
Article CAS PubMed Google Scholar
Hillman J, Aneman O, Anderson C, Sjögren F, Säberg C, Mellergård P. A microdialysis technique for routine measurement of macromolecules in the injured human brain. Neurosurgery. 2005;56(6):1264–8. discussion 8-70.
Ronne-Engström E, Cesarini KG, Enblad P, Hesselager G, Marklund N, Nilsson P, et al. Intracerebral microdialysis in neu-rointensive care: the use of urea as an endogenous reference compound. J Neurosurg. 2001;94(3):397–402.
Tobieson L, Ghafouri B, Zsigmond P, Rossitti S, Hillman J, Marklund N. Dynamic protein changes in the perihaemorrhagic zone of Surgically Treated Intracerebral Haemorrhage Patients. Sci Rep. 2019;9(1):3181.
Article PubMed PubMed Central Google Scholar
Skjøth-Rasmussen J, Schulz M, Kristensen SR, Bjerre P. Delayed neurological deficits detected by an ischemic pattern in the extracellular cerebral metabolites in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2004;100(1):8–15.
Kett-White R, Hutchinson PJ, Al-Rawi PG, Gupta AK, Pickard JD, Kirkpatrick PJ. Adverse cerebral events detected after subarachnoid hemorrhage using brain oxygen and microdialysis probes. Neurosurgery. 2002;50(6):1213–21. discussion 21-2.
Helbok R, Kofler M, Schiefecker AJ, Gaasch M, Rass V, Pfausler B, et al. Clinical Use of Cerebral Microdialysis in Patients with Aneurysmal Subarachnoid Hemorrhage-State of the Art. Front Neurol. 2017;8:565.
Article PubMed PubMed Central Google Scholar
Sarrafzadeh A, Copin JC, Bengualid DJ, Turck N, Vajkoczy P, Bijlenga P, et al. Matrix metalloproteinase-9 concentration in the cerebral extracellular fluid of patients during the acute phase of aneurysmal subarachnoid hemorrhage. Neurol Res. 2012;34(5):455–61.
Article CAS PubMed Google Scholar
Maurer MH, Berger C, Wolf M, Fütterer CD, Feldmann RE Jr, Schwab S, et al. The proteome of human brain microdialysate. Proteome Sci. 2003;1(1):7.
Article PubMed PubMed Central Google Scholar
Olausson P, Gerdle B, Ghafouri N, Larsson B, Ghafouri B. Identification of proteins from interstitium of trapezius muscle in women with chronic myalgia using microdialysis in combination with proteomics. PLoS ONE. 2012;7(12): e52560.
Article CAS PubMed PubMed Central Google Scholar
Talhada D, Gonçalves I, Reis Santos C, Ruscher K. Transthyretin expression in the postischemic brain. PLoS ONE. 2019;14(9): e0221555.
Article CAS PubMed PubMed Central Google Scholar
Bäckryd E, Ghafouri B, Carlsson AK, Olausson P, Gerdle B. Multivariate proteomic analysis of the cerebrospinal fluid of patients with peripheral neuropathic pain and healthy controls - a hypothesis-generating pilot study. J Pain Res. 2015;8:321–33.
Article PubMed PubMed Central Google Scholar
Sörgjerd K, Ghafouri B, Jonsson BH, Kelly JW, Blond SY, Hammarström P. Retention of misfolded mutant transthyretin by the chaperone BiP/GRP78 mitigates amyloidogenesis. J Mol Biol. 2006;356(2):469–82.
Haltmeier T, Inaba K, Durso J, Khan M, Siboni S, Cheng V, et al. Transthyretin at Admission and Over Time as a Marker for Clinical Outcomes in Critically Ill Trauma Patients: A Prospective Single-Center Study. World J Surg. 2020;44(1):115–23.
Raguso CA, Dupertuis YM, Pichard C. The role of visceral proteins in the nutritional assessment of intensive care unit patients. Curr Opin Clin Nutr Metab Care. 2003;6(2):211–6.
Article CAS PubMed Google Scholar
Chen D, Bao L, Lu SQ, Xu F. Serum albumin and prealbumin predict the poor outcome of traumatic brain injury. PLoS ONE. 2014;9(3): e93167.
Article PubMed PubMed Central Google Scholar
Shimauchi-Ohtaki H, Tosaka M, Ohtani T, Iijima K, Sasaguchi N, Kurihara H, et al. Systemic metabolism and energy con-sumption after microsurgical clipping and endovascular coiling for aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien). 2018;160(2):261–8.
Badjatia N, Monahan A, Carpenter A, Zimmerman J, Schmidt JM, Claassen J, et al. Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage. Neurology. 2015;84(7):680–7.
Article CAS PubMed PubMed Central Google Scholar
Marchi N, Fazio V, Cucullo L, Kight K, Masaryk T, Barnett G, et al. Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption. J Neurosci. 2003;23(5):1949–55.
Article CAS PubMed PubMed Central Google Scholar
Blyth BJ, Farhavar A, Gee C, Hawthorn B, He H, Nayak A, et al. Validation of serum markers for blood-brain barrier dis-ruption in traumatic brain injury. J Neurotrauma. 2009;26(9):1497–507.
Article PubMed PubMed Central Google Scholar
Isono N, Imamura Y, Ohmura K, Ueda N, Kawabata S, Furuse M, et al. Transthyretin Concentrations in Acute Stroke Patients Predict Convalescent Rehabilitation. J Stroke Cerebrovasc Dis. 2017;26(6):1375–82.
Gao C, Zhang B, Zhang W, Pu S, Yin J, Gao Q. Serum prealbumin (transthyretin) predict good outcome in young patients with cerebral infarction. Clin Exp Med. 2011;11(1):49–54.
Article CAS PubMed Google Scholar
D’Aguanno S, Franciotta D, Lupisella S, Barassi A, Pieragostino D, Lugaresi A, et al. Protein profiling of Guillain-Barrè syndrome cerebrospinal fluid by two-dimensional electrophoresis and mass spectrometry. Neurosci Lett. 2010;485(1):49–54.
Comments (0)